Codexis analyst coverage
WebAccomplished corporate executive (as CFO, VP of Business Development, and Board Member) supplemented with 20+ years of Wall Street … WebMar 28, 2024 · Pros. Decent infrastructure for data management. Cons. Codexis just laid off a fifth of their workforce 3 months ago under the auspices of having budgetary problems. …
Codexis analyst coverage
Did you know?
WebMar 1, 2024 · By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 7.5% per year. ... We have … WebApr 5, 2024 · Analysts Have Just Cut Their Codexis, Inc. (NASDAQ:CDXS) Revenue Estimates By 10% Jul 28. Codexis: Profitability, Return On Capital Are Persistent Headwinds Looking Ahead Jul 27. Codexis, Inc. Announces CEO Changes, Effective August 9, 2024. ... Help Center Latest Coverage Podcasts Affiliate Program.
WebJul 28, 2024 · The latest analyst coverage could presage a bad day for Codexis, Inc. (NASDAQ:CDXS), with the analysts making across-the-board cuts to their statutory … WebAug 8, 2024 · By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 7.6% per year. ... the analysts also expect Codexis to grow ...
WebMar 20, 2024 · Codexis Price Performance. Codexis stock opened at $3.89 on Thursday. The stock’s fifty day moving average price is $5.55 and its two-hundred day moving average price is $5.68. Codexis has a one ... Web1 day ago · Analyst Forecast According to 14 analysts, the average rating for CDXS stock is "Buy." The 12-month stock price forecast is $13.13, which is an increase of 217.92% from the latest price.
WebApr 6, 2024 · Codexis presently has a consensus price target of $18.83, indicating a potential upside of 362.74%. Icosavax has a consensus price target of $22.50, indicating a potential upside of 254.89%. Given Codexis' higher possible upside, equities research analysts plainly believe Codexis is more favorable than Icosavax.
WebMar 28, 2024 · 1.63%. Trailing 12-Months. The Codexis stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and … mcs registration scotlandWebApr 9, 2024 · Analysts Set New Price Targets. CDXS has been the topic of a number of analyst reports. StockNews.com started coverage on Codexis in a research report on Thursday, March 16th. They issued a ... mcs register solarWebFeb 28, 2024 · There are some variant perceptions on Codexis, with the most bullish analyst valuing it at US$29.00 and the most bearish at US$21.00 per share. ... (with … mcs registration icaiWebJul 15, 2024 · News Profile Analyst Coverage 5 Yr. Financials Dividends Adv. Charts Earnings Options Price History Events Insiders. Codexis Inc. News. INVESTING. Jul 15, 2024 10:45 AM EDT ... Codexis (CDXS ... mcs registration processWebNov 4, 2024 · Additional information about factors that could materially affect actual results can be found in Codexis’ Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 1, 2024, and in Codexis’ Quarterly Report on Form 10-Q filed with the SEC on August 6, 2024, including under the caption “Risk … life is strange hltbWebThese Analysts Think Codexis, Inc.'s (NASDAQ:CDXS) Sales Are Under Threat. Yahoo. 02/27 05:14. Q4 2024 Codexis Inc Earnings Call. Yahoo. 02/24 10:13. Codexis (CDXS) Reports Q4 Loss, Tops Revenue Estimates. ... Analyst Coverage. Price (52 Week Range) $3.85 Upgrade. Upgrade. Price Target ... life is strange how long to beatWebFeb 27, 2024 · Following the latest downgrade, the six analysts covering Codexis provided consensus estimates of US$76m revenue in 2024, which would reflect a sizeable 45% decline on its sales over the past 12 ... life is strange hospital ending